Inside Sanofi’s Genomic Medicine Vision with Mike Quigley, Ph.D.

We love to hear from our listeners. Send us a message. On episode 112 of Cell & Gene: The Podcast, Michael Quigley, Ph.D., Chief Scientific Officer and Global Head of Research at Sanofi talks to Host Erin Harris about the establishment of Sanofi’s dedicated Genomic Medicine Unit (GMU). Dr. Quigley emphasizes in vivo delivery and process optimization to improve patient experience, scalability, and global access. They discuss the importance of partnerships with academia, industry, and regulators, and Dr. Quigley discusses how advances in AI are accelerating research efficiency, molecule optimization, and experimental design across Sanofi’s portfolio. He also points to the breakthroughs likely to revolutionize immunology and gene therapy, such as solutions to pre-existing immunity barriers, improved tissue-specific delivery, regulated and reversible gene therapies, and more precise gene editing. Cell & Gene: The Podcast and Cell & Gene are part of the Life Science Connect family of resources.

You can listen to Inside Sanofi’s Genomic Medicine Vision with Mike Quigley, Ph.D. online on Radio and Podcast. Open the player on this page to stream the available audio.

Inside Sanofi’s Genomic Medicine Vision with Mike Quigley, Ph.D. is an episode from Cell & Gene: The Podcast by Erin Harris.

This episode is 24:15 long.

This episode was published on Sep 25, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Cell & Gene: The Podcast when more episodes are available from the podcast feed.